Skip to content
Disclosery

Atle Fund Management AB

Follow

13F filer, CIK 1381843, STOCKHOLM, Sweden

Atle Fund Management AB reported $313,442,282 across 39 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-06. Its ten largest share positions make up 52.99% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001381843-26-000002

Period
2025-12-31
Reported value
$313M
Holdings
39
Top 10 weight
52.99%
New
8
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CVSnew+106,518$8.45M
IONSnew+92,377$7.31M
INCYnew+70,851$7M
INSMnew+27,873$4.85M
ABVXnew+31,590$4.26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LLYreduced-6,111-$6.57M
GILDreduced-27,373-$3.36M
BBIOreduced-33,426-$2.56M
KRYSreduced-8,338-$2.06M
CORreduced-4,835-$1.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001381843-26-000002, largest first. % of portfolio is the value over $313,442,282, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,564 shares; 2024Q4: 37,068 shares; 2025Q1: 34,602 shares; 2025Q2: 38,721 shares; 2025Q3: 37,244 shares; 2025Q4: 31,133 shares 31,133$33.5M10.67%-6,111Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,486 shares; 2024Q4: 90,723 shares; 2025Q1: 89,227 shares; 2025Q2: 86,933 shares; 2025Q3: 92,105 shares; 2025Q4: 108,181 shares 108,181$24.7M7.89%+16,076Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,699 shares; 2024Q4: 105,727 shares; 2025Q1: 127,679 shares; 2025Q2: 139,172 shares; 2025Q3: 160,913 shares; 2025Q4: 195,768 shares 195,768$20.6M6.57%+34,855Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,012 shares; 2024Q4: 24,896 shares; 2025Q1: 22,857 shares; 2025Q2: 24,266 shares; 2025Q3: 27,147 shares; 2025Q4: 29,915 shares 29,915$17.3M5.53%+2,768Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,607 shares; 2024Q4: 67,763 shares; 2025Q1: 75,881 shares; 2025Q2: 88,392 shares; 2025Q3: 102,625 shares; 2025Q4: 94,796 shares 94,796$13.4M4.29%-7,829Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 15,345 shares; 2025Q2: 18,559 shares; 2025Q3: 19,707 shares; 2025Q4: 22,322 shares 22,322$12.6M4.03%+2,615Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,900 shares; 2025Q1: 25,141 shares; 2025Q2: 24,386 shares; 2025Q3: 30,333 shares; 2025Q4: 40,432 shares 40,432$12.3M3.92%+10,099Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,432 shares; 2024Q4: 103,032 shares; 2025Q1: 151,348 shares; 2025Q2: 165,480 shares; 2025Q3: 174,722 shares; 2025Q4: 141,296 shares 141,296$10.8M3.45%-33,426Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,993 shares; 2024Q4: 22,257 shares; 2025Q1: 22,808 shares; 2025Q2: 24,328 shares; 2025Q3: 17,766 shares; 2025Q4: 22,984 shares 22,984$10.4M3.32%+5,218Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,172 shares; 2024Q4: 154,222 shares; 2025Q1: 132,273 shares; 2025Q2: 126,185 shares; 2025Q3: 86,680 shares; 2025Q4: 108,682 shares 108,682$10.4M3.31%+22,002Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,460 shares; 2024Q4: 25,660 shares; 2025Q1: 22,998 shares; 2025Q2: 27,466 shares; 2025Q3: 22,769 shares; 2025Q4: 26,835 shares 26,835$9.43M3.01%+4,066Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,518 shares 106,518$8.45M2.7%newTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,202 shares; 2024Q4: 9,202 shares; 2025Q1: 23,491 shares; 2025Q2: 20,158 shares; 2025Q3: 42,191 shares; 2025Q4: 33,853 shares 33,853$8.35M2.66%-8,338Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 36,544 shares; 2024Q4: 32,553 shares; 2025Q1: 31,553 shares; 2025Q2: 31,466 shares; 2025Q3: 28,608 shares; 2025Q4: 23,773 shares 23,773$8.03M2.56%-4,835Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 82,691 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 92,377 shares 92,377$7.31M2.33%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 62,161 shares; 2025Q1: 54,961 shares; 2025Q2: 82,275 shares; 2025Q3: 85,355 shares; 2025Q4: 90,184 shares 90,184$7.18M2.29%+4,829Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,965 shares; 2024Q4: 27,414 shares; 2025Q1: 26,577 shares; 2025Q2: 23,894 shares; 2025Q3: 13,806 shares; 2025Q4: 21,903 shares 21,903$7.17M2.29%+8,097Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,321 shares; 2024Q4: 116,692 shares; 2025Q1: 77,263 shares; 2025Q2: 106,912 shares; 2025Q3: 93,605 shares; 2025Q4: 89,685 shares 89,685$7.08M2.26%-3,920Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,851 shares 70,851$7M2.23%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,983 shares; 2024Q4: 138,983 shares; 2025Q1: 107,783 shares; 2025Q2: 157,223 shares; 2025Q3: 193,625 shares; 2025Q4: 197,036 shares 197,036$6.91M2.21%+3,411Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 236,610 shares; 2024Q4: 266,499 shares; 2025Q1: 214,778 shares; 2025Q2: 227,224 shares; 2025Q3: 252,875 shares; 2025Q4: 242,473 shares 242,473$6.78M2.16%-10,402Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,547 shares; 2025Q2: 25,302 shares; 2025Q3: 29,991 shares; 2025Q4: 37,579 shares 37,579$6.67M2.13%+7,588Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 76,998 shares; 2025Q2: 73,165 shares; 2025Q3: 78,169 shares; 2025Q4: 50,796 shares 50,796$6.23M1.99%-27,373Timeline
UFPTUFP TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,048 shares; 2024Q4: 23,159 shares; 2025Q1: 21,259 shares; 2025Q2: 21,886 shares; 2025Q3: 22,986 shares; 2025Q4: 22,986 shares 22,986$5.1M1.63%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 27,873 shares 27,873$4.85M1.55%newTimeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 27,500 shares; 2024Q4: 30,680 shares; 2025Q1: 27,688 shares; 2025Q2: 26,797 shares; 2025Q3: 30,297 shares; 2025Q4: 23,470 shares 23,470$4.82M1.54%-6,827Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 31,590 shares 31,590$4.26M1.36%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 37,157 shares; 2025Q4: 41,831 shares 41,831$4.17M1.33%+4,674Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 24,652 shares; 2025Q3: 45,690 shares; 2025Q4: 47,967 shares 47,967$3.81M1.22%+2,277Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 97,438 shares 97,438$3.37M1.07%newTimeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,490 shares; 2024Q4: 35,202 shares; 2025Q1: 25,782 shares; 2025Q2: 13,727 shares; 2025Q3: 13,727 shares; 2025Q4: 14,636 shares 14,636$3.19M1.02%+909Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 584,332 shares 584,332$3.14M1%newTimeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 26,390 shares; 2024Q4: 30,940 shares; 2025Q1: 37,098 shares; 2025Q2: 40,532 shares; 2025Q3: 60,156 shares; 2025Q4: 62,735 shares 62,735$2.9M0.93%+2,579Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,230 shares; 2024Q4: 42,071 shares; 2025Q1: 44,171 shares; 2025Q2: 25,732 shares; 2025Q3: 25,732 shares; 2025Q4: 41,717 shares 41,717$2.72M0.87%+15,985Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,757 shares; 2024Q4: 60,057 shares; 2025Q1: 45,841 shares; 2025Q2: 50,872 shares; 2025Q3: 50,872 shares; 2025Q4: 39,722 shares 39,722$2.64M0.84%-11,150Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 442,423 shares; 2024Q4: 479,644 shares; 2025Q1: 479,644 shares; 2025Q2: 1,105,461 shares; 2025Q3: 1,169,634 shares; 2025Q4: 1,169,634 shares 1,169,634$2.33M0.74%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 119,833 shares; 2025Q2: 147,380 shares; 2025Q3: 203,755 shares; 2025Q4: 111,363 shares 111,363$1.87M0.6%-92,392Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 69,573 shares; 2024Q4: 98,304 shares; 2025Q1: 98,304 shares; 2025Q2: 175,582 shares; 2025Q3: 175,582 shares; 2025Q4: 107,255 shares 107,255$873K0.28%-68,327Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 617,245 shares 617,245$710K0.23%newTimeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EWEDWARDS LIFESCIENCES CORP65,659$542Kshares
MERUS N VMERUS N V47,999$480Kshares
HRMYHARMONY BIOSCIENCES HLDGS IN92,074$269Kshares
RNAMAVIDITY BIOSCIENCES INC51,978$240Kshares
SMMTSUMMIT THERAPEUTICS INC92,737$203Kshares
MREOMEREO BIOPHARMA GROUP PLC764,901$167Kshares
JANXJANUX THERAPEUTICS INC49,820$129Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001381843-26-000002 base2026-02-06acceptance time not in the bulk data set